A BCBA's Guide to Real-World Assessment Challenges and Payor Practice Gaps

Overview & Clinical Significance

The tension between clinical best practices in behavioral assessment and the realities of insurance and Medicaid authorization requirements represents one of the most consequential challenges facing behavior analysts in contemporary practice. This gap directly affects the quality of services that clients receive, the financial sustainability of ABA organizations, the professional satisfaction and ethical wellbeing of practitioners, and the broader credibility of the field.

At its core, this issue centers on CPT code 97151, which covers behavior identification assessment conducted by a qualified healthcare professional. This code encompasses the comprehensive behavioral assessments that form the foundation of effective treatment planning, including direct observation, caregiver interviews, standardized assessment administration, functional behavior assessment, and the development of individualized treatment recommendations. The clinical consensus is clear: thorough, comprehensive assessment is essential for developing effective, individualized treatment plans.

However, the amount of time that payors authorize for assessment under 97151 often falls far short of what is clinically necessary to conduct a comprehensive evaluation. Many insurance companies and Medicaid programs authorize limited hours for initial assessment, require practitioners to justify each hour of assessment time, impose arbitrary timelines for assessment completion, and deny requests for reassessment when clinical circumstances change. This creates a systemic pressure on behavior analysts to compress their assessments into insufficient time frames, to omit components of a comprehensive evaluation, or to absorb the cost of non-billable assessment activities.

The clinical significance is profound. Assessment drives everything that follows in the treatment process. When assessment is compromised by insufficient authorization, treatment plans are built on incomplete information. Goals may not accurately reflect the client's needs. Interventions may not be well-matched to behavioral functions. And the ongoing reassessment that should guide treatment modifications may be delayed or inadequate.

This course addresses this challenge by empowering behavior analysts to submit authorization requests that reflect their clinical recommendations rather than payor policy, to articulate medical necessity rationales that support appropriate assessment authorization, and to document and bill for the medically necessary services they provide. These are not just billing skills. They are clinical and ethical competencies that directly affect client outcomes.

Background & Context

The landscape of ABA funding has undergone dramatic transformation over the past two decades. The expansion of insurance mandates for autism treatment, beginning with state-level legislation and reinforced by federal parity requirements, created unprecedented access to ABA services for families. However, this expansion also introduced the complex dynamics of insurance authorization, utilization management, and medical necessity determination into a field that had previously operated largely outside the traditional healthcare reimbursement system.

The Insurance and Medicaid Special Interest Group referenced in this course has spent years examining the disconnect between clinical assessment practices and payor requirements. Their findings reveal a consistent pattern: payors tend to authorize fewer assessment hours than clinicians determine are necessary, require assessment to be completed within unrealistically short time frames, apply standardized authorization templates that do not account for the complexity of individual cases, and deny reassessment requests despite significant changes in client presentation.

Several factors contribute to this disconnect. Insurance companies and managed care organizations operate under financial incentives to minimize utilization, which creates systemic pressure to limit authorized services. Utilization reviewers may lack specialized knowledge of behavior analysis assessment practices and may apply criteria developed for other healthcare disciplines that do not map well onto the ABA assessment process. Additionally, the ABA field has not always done an effective job of articulating the medical necessity of comprehensive assessment in language that payors understand and accept.

The concept of medical necessity is central to this discussion. In healthcare, medical necessity refers to services that are clinically appropriate and necessary for the diagnosis or treatment of a condition. For ABA assessment, medical necessity rests on the premise that individualized, function-based assessment is required to develop effective treatment plans and that the duration and scope of assessment must be sufficient to gather the information needed to make sound clinical recommendations.

The challenge is that different payors define medical necessity differently, and their definitions may not align with clinical best practices in behavior analysis. Some payors limit initial assessment to a fixed number of hours regardless of case complexity. Others require practitioners to demonstrate why additional assessment hours are needed before authorizing them, creating a catch-22 in which the practitioner cannot complete the assessment needed to justify the assessment time requested.

Historically, many ABA providers have adapted to these constraints by limiting their assessments to fit within authorized hours, absorbing the cost of additional assessment time as non-billable administrative work, or relying on insufficient assessment data to develop treatment plans. Each of these adaptations has negative consequences for clients, practitioners, and organizations. The alternative approach advocated in this course is to submit authorization requests that accurately reflect clinical need and to develop the documentation and advocacy skills needed to support those requests through the authorization process.

Clinical Implications

The practical clinical implications of the assessment-payor gap affect behavior analysts at every stage of the assessment and treatment planning process. Understanding these implications is the first step toward developing strategies to close the gap and provide clinically appropriate services within the realities of the reimbursement environment.

During initial assessment, the most immediate implication is the need to plan assessment activities strategically to maximize the clinical value of every authorized hour. This does not mean rushing through assessment or cutting corners. It means being intentional about which assessment components are most critical for a given client and prioritizing those components within available time. For example, a client referred for severe self-injurious behavior may require extensive functional analysis time, while a client referred for social skills deficits may benefit more from extended naturalistic observation in social settings. Tailoring the assessment plan to the presenting concerns and clinical questions ensures that available time is used most effectively.

When authorized hours are insufficient for a comprehensive assessment, behavior analysts face a clinical decision about how to proceed. The options typically include completing a partial assessment within authorized hours and requesting additional time, providing non-billable assessment services to complete the evaluation, or submitting a treatment plan based on incomplete assessment data. The first option is generally the most appropriate because it maintains the integrity of the assessment process while working within the authorization system. The second option, while well-intentioned, is financially unsustainable and may inadvertently reinforce payor practices that limit authorization. The third option is the most problematic because it compromises treatment quality.

Documentation practices must support both clinical quality and authorization advocacy. Assessment reports should clearly articulate the clinical rationale for the assessment procedures conducted, the findings and their implications for treatment, and the additional assessment activities that would have been conducted with more authorized time and why those activities are medically necessary. This documentation serves dual purposes: it informs treatment planning and it builds the case for adequate assessment authorization.

Reassessment presents its own clinical challenges. The BACB Ethics Code (2022) and clinical best practice require ongoing assessment to evaluate treatment progress and modify interventions as needed. However, payors often limit the frequency and duration of reassessment, or require extensive justification for reassessment requests. Behavior analysts should develop systematic approaches to documenting the need for reassessment, including data showing changes in client presentation, emergence of new target behaviors, transitions between settings or service models, and other clinical indicators that comprehensive reassessment is warranted.

The clinical implications also extend to how behavior analysts communicate with families about the assessment process. Families may not understand why their insurance company authorized fewer hours than the behavior analyst recommended, or why the assessment process takes longer than expected. Transparent communication about the assessment plan, the authorization process, and any limitations imposed by payor practices helps families understand the context of services and can enlist them as advocates for adequate coverage.

Finally, behavior analysts working within organizations must consider how organizational policies and incentives affect assessment practices. Organizations that prioritize billable hours or rapid caseload growth may create implicit pressure to rush through assessments or to begin treatment before assessment is complete. Advocating for assessment practices that prioritize clinical quality over billing efficiency is both a clinical and ethical responsibility.

Ethical Considerations

The gap between clinical assessment best practices and payor authorization practices creates a dense web of ethical considerations for behavior analysts. Several provisions of the BACB Ethics Code (2022) are directly implicated, and navigating these provisions within a challenging reimbursement environment requires both ethical clarity and practical skill.

Code 2.01 (Providing Effective Treatment) establishes the foundational ethical obligation. Effective treatment requires adequate assessment. When payor practices limit assessment to the point where treatment planning is compromised, behavior analysts face an ethical tension between accepting the authorization as given and providing the assessment they believe is clinically necessary. The Ethics Code does not require practitioners to provide unlimited pro bono services, but it does require them to advocate for the services their clients need. This means submitting authorization requests that reflect clinical recommendations rather than simply accepting payor limitations as the ceiling for assessment.

Code 2.13 (Selecting Behavior-Change Interventions) requires that intervention selection be based on the results of a comprehensive assessment. A behavior analyst who begins treatment based on an inadequate assessment because the payor did not authorize sufficient assessment time is potentially violating this standard. The implication is that practitioners must either complete the necessary assessment before beginning treatment or clearly document the limitations of an incomplete assessment and adjust their treatment recommendations accordingly.

Code 3.01 (Behavior-Analytic Assessment) requires that behavior analysts conduct assessments that are adequate for the purpose they serve. Submitting a treatment plan based on an assessment that the practitioner knows is insufficient raises serious ethical concerns. If the assessment is not adequate to support the treatment recommendations, the practitioner should document this limitation, request additional assessment authorization, and modify their recommendations to reflect the available data.

Code 4.01 (Truthfulness) requires behavior analysts to be truthful in their professional communications. This standard applies directly to authorization requests and clinical documentation. Practitioners must accurately represent the assessment services they have provided, the clinical rationale for their recommendations, and the need for additional services. They should not inflate the scope of assessment to justify billing, but they also should not underrepresent the assessment needed to make it fit within arbitrary authorization limits.

Code 2.04 (Discussing Assessment Results) requires behavior analysts to discuss assessment results with relevant parties in a manner that is understandable. When assessment has been limited by payor authorization, practitioners have an ethical obligation to explain to families what assessment was conducted, what was not conducted and why, and how the limitations of the assessment might affect treatment planning. This transparency empowers families to advocate for their own interests and to make informed decisions about their child's services.

The ethical dimension of billing and documentation deserves specific attention. Behavior analysts must accurately document and bill for the services they provide under 97151. Billing for assessment time that was not spent in assessment activities, or failing to bill for legitimate assessment activities that were conducted, both represent ethical and potentially legal violations. The course's emphasis on appropriate documentation and billing practices reflects the reality that ethical assessment practice and accurate billing are inseparable.

There is also an ethical obligation to advocate for systemic change. When individual practitioners encounter payor practices that systematically undermine clinical quality, there is a collective professional responsibility to document these patterns, to engage with professional organizations that advocate for policy change, and to educate payors about the clinical necessity of comprehensive behavioral assessment. This systemic advocacy serves not just individual clients but the broader population of individuals who need ABA services.

Assessment & Decision-Making

Effective decision-making at the intersection of clinical assessment and payor requirements demands a structured approach that balances clinical priorities with reimbursement realities. Behavior analysts who develop strong assessment and decision-making frameworks in this area are better positioned to provide quality services, maintain ethical integrity, and achieve appropriate reimbursement for their work.

The first decision point occurs before assessment begins: determining the scope and duration of assessment that is clinically indicated for a specific client. This determination should be based on the referral concerns and presenting problems, the complexity of the client's behavioral presentation, the number of settings and contexts that need to be assessed, the availability and reliability of existing assessment data, and the specific clinical questions that need to be answered to develop an effective treatment plan. This clinical determination should be documented and should form the basis of the authorization request, regardless of what the payor's standard authorization template provides.

The authorization request itself is a critical decision point. Practitioners must decide whether to request the clinically indicated assessment hours even if they exceed the payor's typical authorization, or to request only what the payor is likely to approve. The course advocates for the former approach: submitting requests that reflect clinical need rather than payor expectations. This requires developing strong medical necessity rationales that articulate why the requested assessment hours are needed for this specific client.

Medical necessity rationales for 97151 authorization requests should address the specific assessment activities planned and their clinical justification, the client-specific factors that make comprehensive assessment particularly important such as complex behavioral presentations, multiple settings of concern, and comorbid conditions, the consequences of inadequate assessment including risk of ineffective treatment and increased long-term costs, and the alignment of the requested assessment with established clinical guidelines and best practices.

When authorization is received for fewer hours than requested, practitioners face another decision point. Options include appealing the authorization decision with additional supporting documentation, completing the highest-priority assessment components within authorized hours and submitting a request for additional time, beginning assessment within authorized hours while clearly documenting the need for additional assessment, or involving the family in advocating for additional authorization through the payor's appeals process. Each of these options has different advantages and should be selected based on the specific circumstances.

Data collection during assessment should be designed to serve both clinical and authorization purposes. Assessment data should clearly demonstrate the medical necessity of the services provided and support requests for additional services when needed. This means documenting not just assessment results but also the clinical reasoning behind assessment decisions, the time spent on each assessment activity and why that time was necessary, and the clinical questions that remain unanswered if assessment was limited by authorization.

For reassessment, the decision-making process should be driven by clinical data indicating the need for comprehensive reevaluation. Specific triggers for reassessment requests include significant changes in the frequency or severity of target behaviors, emergence of new challenging behaviors or skill deficits, transitions between settings or service delivery models, completion of major treatment goals that require reassessment to establish new priorities, and changes in the client's life circumstances that affect behavioral presentation. Documenting these triggers systematically provides the evidence base for reassessment authorization requests.

Finally, behavior analysts should develop decision-making frameworks for how to handle situations in which payor practices consistently and systematically limit assessment below clinically appropriate levels. This may involve escalating concerns within their organization, engaging with professional advocacy organizations, filing formal complaints with insurance regulators, or documenting patterns of denial for use in policy advocacy efforts.

What This Means for Your Practice

The gap between clinical best practices and payor practices in assessment authorization is not something you can solve individually, but there are concrete steps you can take to improve outcomes for your clients and to contribute to systemic change.

First, commit to submitting authorization requests that reflect your clinical judgment rather than payor expectations. This means conducting a clinical determination of the assessment scope needed for each client and requesting that amount of time, even if it exceeds the payor's standard authorization. Document your clinical rationale thoroughly and be prepared to advocate for your request through the authorization process.

Second, develop strong medical necessity documentation skills. Learn the specific language and criteria that different payors use to evaluate 97151 requests, and tailor your documentation to address those criteria while accurately representing your clinical recommendations. This is not about gaming the system. It is about communicating clinical need in language that payors understand and are required to respond to.

Third, track your authorization data systematically. Document what you request, what is authorized, and the discrepancy between the two. This data serves multiple purposes: it supports individual appeals, it identifies patterns across payors that can inform advocacy efforts, and it provides evidence for organizational decision-making about payor relationships.

Fourth, engage families as partners in the authorization process. Educate families about their rights under their insurance plans, including their right to appeal denied or reduced authorizations. Families who understand the clinical importance of comprehensive assessment can be powerful advocates for adequate coverage.

Fifth, participate in professional advocacy efforts to improve payor practices at the systemic level. This might include involvement with professional organizations that engage with insurance regulators, participation in public comment periods for Medicaid policy changes, or contribution to research documenting the relationship between assessment adequacy and treatment outcomes. Individual clinical excellence is necessary but not sufficient. The systemic changes needed to close the assessment-payor gap require collective professional action.